M. Peter Hecht's Insider Trades & SAST Disclosures
M. Peter Hecht's most recent trade in Cyclerion Therapeutics Inc was a trade of 181,818 Common Stock done at an average price of $2.8 . Disclosure was reported to the exchange on March 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M. Peter Hecht.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 25 Mar 2025 | 181,818 | 559,203 (2%) | 0% | 2.8 | 500,000 | Common Stock |
| Cyclerion Therapeutics Inc | Hecht Peter M. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 15,000 | 377,385 (1%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | M. Peter Hecht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 20,000 | 347,385 (1%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | M. Peter Hecht | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 15,000 | 362,385 (1%) | 0% | 0 | Common Stock | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 351,037 | 351,037 | - | - | Series A Convertible Preferred Stock | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 8.68 per share. | 19 May 2023 | 225,000 | 327,385 (1%) | 0% | 8.7 | 1,953,000 | Common Stock |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 430,000 | 430,000 | - | - | Employee Stock Option (Right to Buy) | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 52,950 | 52,950 | - | - | Employee Stock Option (Right to Buy) | |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.28 per share. | 03 Jun 2021 | 823,170 | 2,047,698 (7%) | 2% | 3.3 | 2,699,998 | Common Stock |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 06 May 2021 | 302,000 | 1,224,528 (4%) | 1% | 2.4 | 733,860 | Common Stock |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.53 per share. | 04 May 2021 | 398,001 | 922,528 (3%) | 1% | 2.5 | 1,006,943 | Common Stock |
| Cyclerion Therapeutics Inc | Peter M. Hecht | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 04 May 2021 | 300,000 | 524,527 (1%) | 1% | 2.3 | 687,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges